menu
    • menu

    Company profile for HengRui

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HengRui USA is a wholly owned subsidiary of our parent company Jiangsu Hengrui Medicine. The foundation of HengRui USA is rooted in our parent company Jiangsu Hengrui Medicine’s rich heritage of over 200 pipelines and products across therapeutic areas such as oncology, metabolics, autoimmune, pain management, etc. Our work here at HengRui USA focuses on the multiple stages of the drug development process, from a clinical, r...
    HengRui USA is a wholly owned subsidiary of our parent company Jiangsu Hengrui Medicine. The foundation of HengRui USA is rooted in our parent company Jiangsu Hengrui Medicine’s rich heritage of over 200 pipelines and products across therapeutic areas such as oncology, metabolics, autoimmune, pain management, etc. Our work here at HengRui USA focuses on the multiple stages of the drug development process, from a clinical, regulatory, and pre-commercialization perspective. HengRui USA operates as the U.S. hub for our parent company from our home office location in Princeton, NJ.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HengRuiUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Alexander Park Dr, Princeton, NJ 08540
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hengruius.com/c
    Linkedin
    Linkedin
    https://www.linkedin.com/company/jiangsu-hengrui-pharmaceuticals-co.ltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/HengRuiUSA

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hengrui Pharma, Braveheart Bio Report Positive Phase 2 Results
    Hengrui Pharma, Braveheart Bio Report Positive Phase 2 Results

    30 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hengrui-pharma-and-braveheart-bio-announce-positive-phase-2-results-with-hrsbhb-1893-in-obstructive-hypertrophic-cardiomyopathy-302727515.html

    PR NEWSWIRE
    30 Mar 2026
    Share Share
    Kailera, Hengrui To Advance Oral Obesity Drug Into 2 New Trials
    Kailera, Hengrui To Advance Oral Obesity Drug Into 2 New Trials

    10 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/kailera-hengrui-tout-promising-mid-stage-results-obesity-pill

    FIERCE BIOTECH
    10 Feb 2026
    Share Share
    Hengrui & Kailera Share Ph3 China Data on Dual GLP-1/GIP Agonist
    Hengrui & Kailera Share Ph3 China Data on Dual GLP-1/GIP Agonist

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180679/0/en/Hengrui-Pharma-and-Kailera-Therapeutics-Announce-Additional-Data-from-Phase-3-Obesity-Trial-in-China-of-Dual-GLP-1-GIP-Receptor-Agonist-HRS9531.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Hengrui Pharma, Kailera Therapeutics To Present Phase 3 HRS9531
    Hengrui Pharma, Kailera Therapeutics To Present Phase 3 HRS9531

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170042/0/en/Hengrui-Pharma-and-Kailera-Therapeutics-Announce-Phase-3-HRS9531-Obesity-Data-Presentation-at-ObesityWeek-2025.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Hengrui Unveils Booth At ESMO Featuring Groundbreaking Data
    Hengrui Unveils Booth At ESMO Featuring Groundbreaking Data

    20 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/live-from-esmo--hengrui-debuts-exhibition-booth-with-landmark-data-showcasing-pharmas-emerging-innovation-power-302588729.html

    PR NEWSWIRE
    20 Oct 2025
    Share Share
    Hengrui’s GLP-1/GIP Agonist Reports 18% Weight Loss in Phase 3
    Hengrui’s GLP-1/GIP Agonist Reports 18% Weight Loss in Phase 3

    16 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/hengruis-glp-1gip-agonist-reports-18-weight-loss-phase-3-trial-readies-china-push

    FIERCE BIOTECH
    16 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Contact HengRui and get a quotation

    HengRui is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of COREY 16 bulk with DMF offered by HengRui

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search